Dopamine Uptake InhibitorsDopamineBenztropineNomifensineDopamine Plasma Membrane Transport ProteinsCocaineReceptors, Dopamine D25,7-DihydroxytryptamineMicrodialysisNeostriatumNeurotransmitter Uptake InhibitorsTropanesPiperazinesDopamine AntagonistsReceptors, Dopamine D1MazindolMembrane Transport ProteinsReceptors, DopamineDopamine AgonistsNortropanesReceptors, Dopamine D3Corpus StriatumDopamine AgentsNorepinephrine Plasma Membrane Transport ProteinsNerve Tissue ProteinsSynaptosomesAmphetamineAdrenergic Uptake InhibitorsMembrane GlycoproteinsNucleus AccumbensRats, Sprague-DawleyMethamphetamineReceptors, Dopamine D5MethylphenidateCarrier ProteinsVesicular Monoamine Transport ProteinsCaudate NucleusBiological TransportSerotoninGABA Uptake InhibitorsDose-Response Relationship, DrugSerotonin Plasma Membrane Transport ProteinsMotor ActivityMembrane Transport ModulatorsDopamine beta-HydroxylasePutamenBehavior, AnimalBrainSubstantia NigraSerotonin Uptake InhibitorsRacloprideATP-Binding Cassette TransportersCentral Nervous System StimulantsLobelineFluoxetineQuinpiroleTetrabenazineMesencephalonDesipramineBiogenic MonoaminesNipecotic AcidsNorepinephrineBenzazepinesTyrosine 3-MonooxygenaseCocaine-Related DisordersDopaminergic Neurons1-Methyl-4-phenylpyridiniumZimeldineNeuronsStereotyped BehaviorDrug InteractionsSelf AdministrationBrain ChemistryLevodopaSalicylamidesOrganic Anion TransportersSulpirideTomography, Emission-Computed, Single-PhotonClomipramineHaloperidolHomovanillic AcidBinding, CompetitiveTritiumKineticsReserpineSymporters3,4-Dihydroxyphenylacetic AcidOxidopamineTime FactorsDextroamphetamineParkinsonian DisordersAmphetaminesIodine RadioisotopesSerotonin AntagonistsVentral Tegmental AreaApomorphineN-Methyl-3,4-methylenedioxyamphetaminealpha-MethyltyrosinePargylineRadiopharmaceuticals